75N91018F00077↗
Leidos Biomedical Research Inc received this contract from Nih Nci, National Institutes of Health: $20.22M obligated so far for operation of government-owned contractor-operated (goco) r&d facilities. It runs to 2029-08-29.
Key facts · data as of Oct 26, 2026
- Recipient
- Leidos Biomedical Research Inc
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- Nih Nci (75N910)
- Obligated to date
- $20.22M
- Potential value
- $53.52M
- Ends
- 2029-08-29
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 75N91018F00077, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75N91018F00077_7529_HHSN261201500003I_7529
Leidos Biomedical Research Inc: all federal awards · Department of Health and Human Services: spending · Nih Nci: what it buys
CELL-BASED IMMUNOTHERAPY PRODUCTS
What it is
- Product or service
- Operation of Government-Owned Contractor-Operated (Goco) R&D Facilities (PSC M1HA)
- Industry
- Facilities Support Services (NAICS 561210)
- Contracting office
- Nih Nci (75N910)
- Competition
- Not competed
- Pricing
- Cost plus fixed fee
- How it was bought
- Single-award IDIQ · under HHSN261201500003I
- Solicitation
- N01CO5240180
- Where the work is
- Frederick, MD · district MD-06
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
2 subawards totaling $219.5K (1.1% of what was obligated), as Leidos Biomedical Research Inc reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Government Scientific Source Inc | $150.3K | 1 | VA | 2023-02-17 | 2023-02-17 |
| Franklin Young International, Incorporated | $69.2K | 1 | CA | 2023-03-16 | 2023-03-16 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2023-02-17 | Government Scientific Source Inc | $150.3K | 1 EACH, PART # MAESTRO-TRAYZ-2, MAESTRO TRAYZ WITH TWO TRAYS, MULTIPLATE INCUBATOR-BASED IMPENDANCE SYSTEM WITH BIOCORE V4 CHIP TECHNOLOGY, RECORDING AND DATA ACQUISITION SYSTEM. 1 EACH PART # INT-OS, INSTALLATION AND… |
| 2023-03-16 | Franklin Young International, Incorporated | $69.2K | PURCHASE OF CAPITAL EQUIPMENT (4) AIR PARTICLE COUNTER. |
Every action
9 actions since 2023-02-22. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-08-22 | P00013 | Administrative change | $0 | MOD 13 - SOW REVISION PER NCI COR (RAY HARRIS) REQUEST |
| 2025-04-23 | P00012 | Administrative change | $0 | EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI |
| 2024-08-30 | P00011 | Administrative change | $13.63M | CELL-BASED IMMUNOTHERAPY PRODUCTS MOD 011 - EXERCISE OPTION 02 |
| 2024-08-22 | P00010 | Funding only | -$541.9K | CELL-BASED IMMUNOTHERAPY PRODUCTS MOD 010 - PLIN 2 DE-OBLIGATION |
| 2024-03-14 | P00009 | Administrative change | $541.7K | CELL-BASED IMMUNOTHERAPY PRODUCTS MOD 009 |
| 2023-09-29 | P00008 | Administrative change | $0 | CELL-BASED IMMUNOTHERAPY PRODUCTS |
| 2023-08-25 | P00007 | Administrative change | $6.59M | CELL-BASED IMMUNOTHERAPY PRODUCTS |
| 2023-05-02 | P00006 | Administrative change | $0 | CELL-BASED IMMUNOTHERAPY PRODUCTS |
| 2023-02-22 | P00005 | Administrative change | $0 | CELL-BASED IMMUNOTHERAPY PRODUCTS |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗